Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy post-exposure prophylaxis risks not adequately assessed

Lockwood DNJ, De Barros B, Negera E, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (4) : e400-e401.
Download PDF
Publication

Leprosy post-exposure prophylaxis risks not adequately assessed – Author's reply

Richardus JH, Mieras L, Saunderson P, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (4) : e402-e403.
Download PDF
Publication

Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study.

Taal A, Blok D, van Brakel WH, et al. PLoS neglected tropical diseases. 2021; 15 (2) : e0009146.
Download PDF
Publication

Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients.

Hacker MA, Sales A, Duppre NC, et al. Scientific reports. 2021; 11 (1) : 1947.
Download PDF
Publication

Contatos intradomiciliares: aspectos epidemiológicos e sua importância para eliminação da hanseníase

Wilian Lozano A, Martins Pinto Neto J, Femina LL, et al. Revista Científica de Enfermagem. 2020; 10 (32) : 11-23.
Download PDF
Publication

CCL2 and IFN-γ serum levels as biomarker for subclinical infection in household contacts of leprosy patients.

Queiroz E, Medeiros N, Mattos R, et al. Microbial pathogenesis. 2021;

Transmission

  • Read more about Transmission
Publication

Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts.

Marçal PHF, Gama R, de Oliveira L, et al. Infectious diseases of poverty. 2020; 9 (1) : 167.
Download PDF
Publication

Single-Nucleotide Polymorphisms in Genes Predisposing to Leprosy in Leprosy Household Contacts in Zhejiang Province, China

Shen Y, Long S, Kong W, et al. Informa UK Limited. Pharmacogenomics and Personalized Medicine. 2020;
Download PDF
Publication

VIGILÂNCIA EM SAÚDE PARA IDENTIFICAÇÃO PRECOCE E ACOMPANHAMENTO DOS CASOS DE HANSENÍASE NA UNIDADE BÁSICA DE SAÚDE

Neto HFV, Gomes LDMA. Universidade Federal do Piauí (UFPI). 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 11
  • Next page ››
Subscribe to Contacts / Contact tracing

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD